Production, purification and formulation of Nanoradiopharmaceutical with 211At: An emerging candidate for targeted alpha therapy

2024-11-1

Structure-affinity-pharmacokinetics relationships of 111In-labeled PSMA-targeted ligands with different albumin binders

2024-11-1

Preclinical evaluation of [225Ac]Ac-crown-TATE – An alpha-emitting radiopharmaceutical for neuroendocrine tumors

2024-11-1

Automation of simplified two-step radiolabeling via ditosylate synthon for 18F-labeled radiotracers using AllinOne module

2024-9-1

Towards imaging the immune state of cancer by PET: Targeting legumain with 11C-labeled P1-Asn peptidomimetics carrying a cyano-warhead

2024-9-1

Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen

2024-9-1

Evaluation of heterotopic ossification maturity using SPECT/CT and PET/CT in preclinical model

2024-9-1

The importance of radiochemical purity: Cellular binding and internalization of different radiometal chlorides in prostate cancer cells

2024-9-1

[89Zr]ZrCl4 for direct radiolabeling of DOTA-based precursors

2024-9-1

Synthesis and characterization of 64Cu-labeled Geldanamycin derivative for imaging HSP90 expression in breast cancer

2024-9-1

Actinium-225 photonuclear production in nuclear reactors using a mixed radium-226 and gadolinium-157 target

2024-9-1

An electrochemical generator for the continual supply of 213Bi from 225Ac for use in targeted alpha therapy applications

2024-9-1

Preclinical evaluation of MC1R targeting theranostic pair [155Tb]Tb-crown-αMSH and [161Tb]Tb-crown-αMSH

2024-9-1

Synthesis and preclinical evaluation of [18F]AlF-NODA-MP-C6-CTHRSSVVC as a PET tracer for CD163-positive tumor-infiltrating macrophages

2024-8-10

Preclinical investigation of the effect of stress on the binding of [18F]F13640, a 5-HT1A radiopharmaceutical

2024-7-23

Transcatheter pseudo-vascular isolation for localization and concentration of a large molecule theranostic probe into a transgenic OncoPIG kidney tumor

2024-7-3

Editorial Board

2024-7-1

Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information

2024-7-1

[18F]FMISO-PET imaging reveals the role of hypoxia severity in checkpoint blockade response

2024-7-1

Study of activation cross sections of double neutron capture reaction on 193Ir for the reactor production route of radiotherapeutic 195mPt

2024-7-1

Combining poly-epitope MoonTags and labeled nanobodies for signal amplification in cell-specific PET imaging in vivo

2024-6-20

Target engagement of an anti-MT1-MMP antibody for triple-negative breast cancer PET imaging and beta therapy

2024-5-23

Tracking the fate of bacteria-derived site-specific immunomodulators by positron emission tomography

2024-5-1

A third generation PSMA-targeted agent [211At]YF2: Synthesis and in vivo evaluation

2024-5-1

Editorial Board

2024-5-1

Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcoma

2024-5-1

Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information

2024-5-1

Development of 225Ac/213Bi generator based on α-ZrP-PAN composite for targeted alpha therapy

2024-5-1

Reduction of the hepatic radioactivity levels of [111In]In-DOTA–labeled antibodies via cleavage of a linkage metabolized in lysosomes

2024-4-8

Synthesis and evaluation of novel trifunctional chelating agents for pretargeting approach using albumin binder to improve tumor accumulation

2024-4-5

Application of copper (I) selective ligands for PET imaging of reactive oxygen species through metabolic trapping

2024-4-1

PSMA-reactive NB7 single domain antibody fragment: A potential scaffold for developing prostate cancer theranostics

2024-4-1

Chemokine receptor PET imaging: Bridging molecular insights with clinical applications

2024-4-1

Synthesis and evaluation of a 68Ga-labeled spermine derivative for tumor PET imaging

2024-4-1

The future of the radiopharmaceutical sciences

2024-3-27

Second generation Al18F-labeled D-amino acid peptide for CXCR4 targeted molecular imaging

2024-3-19

Investigation of imaging the somatostatin receptor by opening the blood-brain barrier with melittin – A feasibility study using positron emission tomography and [64Cu]Cu-DOTATATE

2024-3-19

Evaluation of acute intravenous toxicity of HEPES: Is Good's buffer good and safe enough for clinical utilization in nuclear medicine?

2024-3-9

Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information

2024-3-1

Editorial Board

2024-3-1

In vitro evaluation of [3H]PI-2620 and structural derivatives in non-Alzheimer's tauopathies

2024-3-1

Improved purification of cyclotron [68Ga]GaCl3 for the production of 68Ga radiopharmaceuticals

2024-2-25

Serotonin transporter imaging agent as a probe for β-cells of pancreas

2024-2-24

Development of a CCR2 targeted 18F-labeled radiotracer for atherosclerosis imaging with PET

2024-2-23

Advancements in the development of radiopharmaceuticals for nuclear medicine applications in the treatment of bone metastases

2024-2-3

Biodistribution study of 211Pb progeny released from intravenously applied 223Ra labelled TiO2 nanoparticles in a mouse model

2024-2-1

Evaluation of targeting αVβ3 in breast cancers using RGD peptide-based agents

2024-2-1

Editorial Board

2024-1-1

Evaluation of a novel hexadentate 1,2-hydroxypyridinone-based acyclic chelate, HOPO-O6-C4, for 43Sc/47Sc, 68Ga, and 45Ti radiopharmaceuticals

2024-1-1

Evaluation of F-537-Tetrazine in a model for brain pretargeting imaging. Comparison to N-(3-[18F] fluoro-5-(1,2,4,5-tetrazin-3-yl)benzyl)propan-1-amine

2024-1-1